期刊文献+

中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版) 被引量:7

Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)
原文传递
导出
摘要 肝脏虽为“免疫特惠器官”,肝移植术后急性排斥反应发生率及严重程度明显低于其他器官移植,但术后排斥反应仍较为常见,规范的免疫抑制治疗是保证移植效果的关键。为进一步规范肝移植术后免疫抑制治疗及排斥反应诊疗,中华医学会器官移植学分会组织肝移植专家,总结国内外相关研究最新进展,并结合国际指南和临床实践,针对肝移植术后免疫抑制剂应用原则、常用方案及各类型排斥反应的诊断与治疗,制订《中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)》。
出处 《中华移植杂志(电子版)》 CAS 2019年第4期262-268,共7页 Chinese Journal of Transplantation(Electronic Edition)
  • 相关文献

参考文献3

二级参考文献64

  • 1段丽君,江霞.糖皮质激素在器官移植中的应用[J].实用器官移植电子杂志,2014,2(2):77-79. 被引量:4
  • 2Nematullah Sharaf,Richard A. Prayson.Relapsing polymyositis in chronic graft versus host disease[J].Journal of Clinical Neuroscience.2014
  • 3Asha R. Patel,Daniele Avila,Harry L. Malech,Steven Z. Pavletic,Larry Yao,Edward W. Cowen.Rippled skin, fasciitis, and joint contractures[J].Journal of the American Academy of Dermatology.2008(6)
  • 4Alexandra H. Filipovich,Daniel Weisdorf,Steven Pavletic,Gerard Socie,John R. Wingard,Stephanie J. Lee,Paul Martin,Jason Chien,Donna Przepiorka,Daniel Couriel,Edward W. Cowen,Patricia Dinndorf,Ann Farrell,Robert Hartzman,Jean Henslee-Downey,David Jacobsohn,George McDonald,Barbara Mittleman,J. Douglas Rizzo,Michael Robinson,Mark Schubert,Kirk Schultz,Howard Shulman,Maria Turner,Georgia Vogelsang,Mary E.D. Flowers.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report[J].Biology of Blood and Marrow Transplantation.2005(12)
  • 5Antonio D.Pinna,DeborahWeppler,MarianaBerho,MicheleMasetti,WervistonDeFaria,TomoakiKato,JohnThompson,CamilloRicordi,Andreas G.Tzakis.Unusual presentation of graft‐versus‐host disease in pediatric liver transplant recipients: Evidence of late and recurrent disease[J].Pediatric Transplantation.2002(3)
  • 6Amy B. Hahn,Prabhakar Baligat.Rapid method for the analysis of peripheral chimerismin suspected graft-versus-host disease after liver transplantation[J].Liver Transplantation.2000(2)
  • 7Matthew J. Everly,Jason J. Everly,Brian Susskind,Paul Brailey,Lois J. Arend,Rita R. Alloway,Prabir Roy-Chaudhury,Amit Govil,Gautham Mogilishetty,Adele H. Rike,Michael Cardi,George Wadih,Amit Tevar,E Steve Woodle.Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection[J]. Transplantation . 2008 (12)
  • 8Nimer Assy,Paul C. Adams,Paul Myers,Verra Simon,Gerry Y. Minuk,William Wall,Cameron N. Ghent.Randomized Controlled Trial of Total Immunosuppression Withdrawal in Liver Transplant Recipients: Role of Ursodeoxycholic Acid[J].Transplantation.2007(12)
  • 9K. D. S.Watt,R. A.Pedersen,W. K.Kremers,J. K.Heimbach,M. R.Charlton.Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study[J].American Journal of Transplantation.2010(6)
  • 10S. D. Henry,E. Nachber,J. Tulipan,J. Stone,C. Bae,L. Reznik,T. Kato,B. Samstein,J. C. Emond,J. V. Guarrera.Hypothermic Machine Preservation Reduces Molecular Markers of Ischemia/Reperfusion Injury in Human Liver Transplantation[J]. American Journal of Transplantation . 2012 (9)

共引文献36

同被引文献56

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部